The Japanese pharmaceutical company has filed a cluster of lawsuits against generic drug makers asserting its patent protection and market exclusivity over the high-selling ALS treatment.
Speakers include Raymond Doss, associate general counsel for IP and litigation at Amgen, Reena Bajpai, senior counsel at Gilead Sciences, Sanjesh Sharma, assistant general counsel for patents at ...
Panellists discuss data, AI and patents in a session at the CIPA Annual Congress 2025. L-R: Greg Corcoran, Rose Hughes, Ben Hoyle, Coreena Brinck, Julio Fonseca If you don't have a login or your ...
27 May 2025 Litigation concerns Novartis’ blockbuster $6bn heart failure drug, which has already expired | Indian generic company hoped to stay proceedings to prepare appeal against unfavourable ...
A recent survey shows heavy opposition to the proposal which could leave university licensing struggling, chill investment in startups, and threaten technology transfers. If you don't have a login or ...
8 May 2025 Industry body says agreement doesn’t address ‘longstanding industry concerns’ about IP | Deal criticised for ‘lack of detail’ on IP, particularly for UK life sciences and general legal ...
The new addition by Latham & Watkins is a “distinguished practitioner” and marks another departure from Simmons & Simmons. If you don't have a login or your access has expired, you will need to ...
Commoditising work using AI is a ‘moral obligation’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback